Ondansetron Hydrochloride
Ondansetron Hydrochloride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Ondansetron Hydrochloride; Generic name: ONDANSETRON HYDROCHLORIDE; Manufacturer: PD-Rx Pharmaceuticals, Inc..
| Brand name | Ondansetron Hydrochloride |
|---|---|
| Generic name | ONDANSETRON HYDROCHLORIDE |
| Manufacturer | PD-Rx Pharmaceuticals, Inc. |
| Used for | 1 INDICATIONS AND USAGE Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 initial and repeat courses of moderately emetogenic cancer chemotherapy radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting. Ondansetron tablets are a 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cispl |
| Dosage | 2 DOSAGE AND ADMINISTRATION See full prescribing information for the recommended dosage in adults and pediatrics. (2) Patients with severe hepatic impairment: do not exceed a total daily dose of 8 mg. (2.2 , 8.6 ) 2.1 Recommended Dosage The recommended dosage regimens for adult and pediatric patients are described in Table 1 and Table 2, respectively. Corresponding doses of ondansetron tablets, ondansetron orally disintegrating tablets and ondansetron oral solution may be used interchangeably. T |
| Active ingredient(s) | ONDANSETRON HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b675b09-fe40-435c-b91a-c61cdf767fbf |